Form 4: Security National Financial Corp: VP Overbaugh Reports Stock Transactions and Option Awards
SEC Form 4
Jason G. Overbaugh, VP & National Marketing Director of Life Insurance at Security National Financial Corp, reports acquisition of shares through option exercise and disposition of shares through sales.
Summary
- Jason G. Overbaugh, a VP at Security National Financial Corp (SNFCA), filed a Form 4 detailing changes in beneficial ownership.
- On October 30, 2024, Overbaugh acquired 16,542 shares of Class A Common Stock at $10.025 per share through the exercise of options.
- On October 31, 2024, Overbaugh sold 2,500 shares of Class A Common Stock at $9.78 per share.
- Following these transactions, Overbaugh directly owns 116,239 shares of Class A Common Stock, excluding 105,501 shares held indirectly in a 401(k) plan.
- Overbaugh also holds options to purchase a total of 255,127 shares of Class C Common Stock at various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing primarily reports routine stock transactions. The option exercise is a positive sign, while the sale is a minor negative, balancing out the overall sentiment.
Positives
- The exercise of stock options indicates Overbaugh's confidence in the company's future performance.
Negatives
- The sale of 2,500 shares may be perceived negatively, although it could be for personal financial management.
Risks
- Executive stock sales can sometimes signal a lack of confidence, although this sale is relatively small.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Comparison to Industry Standards
- Comparing Overbaugh's transactions to those of executives at similar financial services companies like American National Group or CNO Financial Group would provide context on whether these actions are typical.
- Analyzing the frequency and size of insider transactions across the industry can help determine if these moves are aligned with standard practices.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how they are interpreted.
Key Dates
| Date | Description |
|---|---|
| 12/02/2016 | Date of grant for an option to purchase 20,000 shares of Class A Common Stock (adjusted to 30,289 shares due to stock dividends). |
| 03/02/2017 | First exercisable date for the option granted on December 2, 2016. |
| 12/01/2017 | Date of grant for an option to purchase 20,000 shares of Class A or Class C Common Stock (adjusted to 28,847 shares due to stock dividends). |
| 03/01/2018 | First exercisable date for the option granted on December 1, 2017. |
| 11/30/2018 | Date of grant for an option to purchase 25,000 shares of Class A or Class C Common Stock (adjusted to 34,340 shares due to stock dividends). |
| 02/28/2019 | First exercisable date for the option granted on November 30, 2018. |
| 12/06/2019 | Date of grant for an option to purchase 30,000 shares of Class A or Class C Common Stock (adjusted to 39,246 shares due to stock dividends). |
| 03/06/2020 | First exercisable date for the option granted on December 6, 2019. |
| 03/27/2020 | Date of grant for an option to purchase 30,000 shares of Class A or Class C Common Stock (adjusted to 37,377 shares due to stock dividends). |
| 06/27/2020 | First exercisable date for the option granted on March 27, 2020. |
| 12/03/2021 | Date of grant for an option to purchase 30,000 shares of Class A or Class C Common Stock (adjusted to 34,729 shares due to stock dividends). |
| 03/03/2022 | First exercisable date for the option granted on December 3, 2021. |
| 12/02/2022 | Date of grant for an option to purchase 35,000 shares of Class A or Class C Common Stock (adjusted to 38,588 shares due to stock dividends). |
| 03/02/2023 | First exercisable date for the option granted on December 2, 2022. |
| 12/01/2023 | Date of grant for an option to purchase 40,000 shares of Class A or Class C Common Stock (adjusted to 42,000 shares due to stock dividends). |
| 03/01/2024 | First exercisable date for the option granted on December 1, 2023. |
| 10/30/2024 | Date of transaction: Acquisition of 16,542 shares of Class A Common Stock through option exercise. |
| 10/31/2024 | Date of transaction: Sale of 2,500 shares of Class A Common Stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.